This HTML5 document contains 151 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33348137
rdf:type
wikibase:Item
schema:description
научна статия 2003年论文 articolo scientifico artikulong pang-agham 2003年论文 bilimsel makale vědecký článek наукова стаття, опублікована в червні 2003 2003年論文 مقالهٔ علمی 2003年论文 mokslinis straipsnis επιστημονικό άρθρο bài báo khoa học мақолаи илмӣ научни чланак 2003 թվականի հունիսին հրատարակված գիտական հոդված 2003年论文 научная статья artículo científico publicado en 2003 vetenskaplig artikel 2003年论文 artigo científico (publicado na 2003) מאמר מדעי 2003 թուականի Յունիսին հրատարակուած գիտական յօդուած article científic سائنسی مضمون 2003年の論文 2003年論文 article scientific artigo científico 2003년 논문 wetenschappelijk artikel ২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico (publicado na 2003) scientific article мақолаи илмӣ scienca artikolo artículu científicu espublizáu en 2003 videnskabelig artikel (udgivet 2003) articol științific научни чланак სამეცნიერო სტატია 2003年論文 artykuł naukowy artikull shkencor vitenskapelig artikkel مقالة علمية tieteellinen artikkeli 2003年论文 vedecký článok wissenschaftlicher Artikel naučni članak teaduslik artikkel 2003年論文 2003 nî lūn-bûn tudományos cikk 2003年論文 บทความทางวิทยาศาสตร์ article scientifique (publié 2003) vitskapeleg artikkel
p:P577
wds:Q33348137-0AD9D26E-91B9-4811-9E4B-5A30C28AE4FA
wdt:P577
2003-06-01T00:00:00Z
p:P407
wds:Q33348137-E7CBE1DC-264F-422A-80D2-3EFF619D0652
wdt:P407
wd:Q1860
p:P2860
wds:Q33348137-7D4857F9-1737-4DD9-93B4-ABC62E6A8F04 wds:Q33348137-5B5F93FC-64C3-4F98-B758-570FAF1B9055 wds:Q33348137-60138196-975C-4F44-915D-234BD6594531 wds:Q33348137-470A3F22-3F04-40D3-A2E6-6EAD4CA247A3 wds:Q33348137-473660AF-BBBB-491B-BF6A-9D896F305640 wds:Q33348137-18B821D5-B6E3-4241-889B-9A0CAD6B78A5 wds:Q33348137-2D138C17-DC67-4B11-836A-7A483D3F24D6 wds:Q33348137-EE99B867-0EA5-48B7-8B9B-01B79DEC21D2 wds:Q33348137-FF020CD4-382F-4B4D-877A-C8386ED25D3D wds:Q33348137-C5323EB7-2A78-4C6F-8466-FC13205DC4B0 wds:Q33348137-E1CADE45-ABCB-4DAB-B1AA-770CA8F94F4B wds:Q33348137-AFBEFA7C-E522-4F40-8C2C-D4C07EA8C18A wds:Q33348137-B54E4CA9-36CA-4A7B-A8ED-6E54EE4ECF4B wds:Q33348137-BCACC6AC-4B2B-4BB0-93F7-8138E8C895DB wds:Q33348137-9901B1B0-F87C-49F6-80FC-00E25D9C0C82 wds:Q33348137-816922AC-1141-49FF-977F-FB4DA410A115 wds:Q33348137-8615E14E-9311-4024-B51E-1FC40EC5A382 wds:Q33348137-67EDA75C-4486-4C0E-889D-143A432ECEA5
wdt:P2860
wd:Q57560445 wd:Q55478945 wd:Q43573415 wd:Q48405089 wd:Q33489402 wd:Q36081960 wd:Q24683819 wd:Q33341861 wd:Q33345025 wd:Q30652041 wd:Q33724545 wd:Q34571908 wd:Q33330748 wd:Q39446219 wd:Q46412217 wd:Q44119212 wd:Q33339923 wd:Q34364191
p:P2093
wds:Q33348137-AF16A020-1FAB-4CDF-9813-7FD896C7497D wds:Q33348137-10E54A26-4257-4DF7-9664-87767E9400E2 wds:Q33348137-08D98527-E5D3-4FA1-9D1F-171183DC32DC wds:Q33348137-92F6003C-4E9D-41DF-A121-C960409F4912 wds:Q33348137-ADBD92AE-EEBE-47EC-87F1-B6C06E01D02C wds:Q33348137-F6C0F2AF-334A-43F4-A923-4C141F7B5F12
wdt:P2093
C Legrand E F Smit A Price C Debruyne A Ardizzoni EORTC Lung Cancer Group
rdfs:label
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965). Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965). Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).
skos:prefLabel
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965). Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965). Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).
schema:name
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965). Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965). Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).
p:P50
wds:Q33348137-54C92757-8BBC-4C34-8F36-544B8CA12537 wds:Q33348137-D07DA9FA-D3F9-4870-B274-0A2E5AC90699 wds:Q33348137-34611CA3-5671-4D20-83E1-34709E94DC43
wdt:P50
wd:Q56826661 wd:Q58328150 wd:Q37829946
p:P1476
wds:Q33348137-206E2698-268B-4DC7-A355-BB9503D4CBF7
wdt:P1476
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).
p:P304
wds:Q33348137-81475358-3578-4976-9CD5-D517E6DF1B0C
wdt:P304
1271-1276
p:P31
wds:Q33348137-73F8C30B-AE30-487F-AB4E-A1FF22B9167D
wdt:P31
wd:Q13442814
p:P921
wds:Q33348137-46DAF3E9-7070-41DD-B26C-04D03EF3F140 wds:Q33348137-EA1CFADE-1CD9-485E-8E40-ECD8F3565DD5
wdt:P921
wd:Q47912 wd:Q425088
p:P698
wds:Q33348137-179CDC49-ECA9-4692-90EC-60232C91F3B4
wdtn:P698
n10:12763216
wdt:P698
12763216
p:P1433
wds:Q33348137-65256E4C-41AF-4B16-B73D-B35E6224D347
wdt:P1433
wd:Q332260
p:P433
wds:Q33348137-8FF23CF7-0E7F-4629-AFDD-0C9129D3EB9E
p:P478
wds:Q33348137-9B84CBEE-0A9B-457B-B416-229134521015
wdt:P433
9
wdt:P478
39
p:P356
wds:Q33348137-A9B8B0D1-E19A-4BE9-85B2-8273138E2915
wdtn:P356
n12:S0959-8049(03)00234-X
wdt:P356
10.1016/S0959-8049(03)00234-X